Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
Journal: American journal of hematology
Published: May 13, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales.
Journal: American journal of hematology
Published: March 05, 2026
CSF3R-mutated chronic neutrophilic leukemia: a two-center study of 44 consecutive patients.
Journal: Haematologica
Published: October 11, 2025
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Journal: American journal of hematology
Published: November 16, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: July 24, 2024
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Journal: American journal of hematology
Published: May 07, 2024
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.
Journal: Blood
Published: April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes.
Journal: European journal of haematology
Published: January 13, 2024
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Journal: American journal of hematology
Published: November 24, 2023
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
Journal: Haematologica
Published: November 21, 2023
Last Updated: 09/26/2026